IPO
Aardvark Therapeutics Gears Up for IPO with Promising Weight Loss Drug
Aardvark Therapeutics, a San Diego-based biotech company, is on track for an initial public offering (IPO) this summer. The company is developing a we...
DISCOVERIES
Upstream Benefits Signal The Making Of The Next Giant Drug Class
New technologies typically don’t address one specific problem. The path to becoming an important force multiplier with population-level impacts is the...
STARTUPS
Tome Biosciences Defies Biotech Gloom
Earlier this year, a Jefferies analyst quantified the market downturn in the biotechnology sector and came up with a number: 128 companies were tradin...
SCIENCE
The Future of Cancer Treatment: The Three Most Promising Emerging Therapies
Cancer remains one of the world’s leading causes of death. Traditional treatments – surgery, radiation therapy, and chemotherapy – have saved co...